Evidence map›Paper›PMID 39441435›Full record

ArticleApplied microscopy2024

Analytical microscopy techniques using coaxial and oblique illuminations to detect thin glass particulates generated from glass vials for parenteral drug products.

Adedayo M Sanni, Adedamola A Opalade, Armen Shamirian, Spencer Mattson, Eric Driscoll, Michael St Martin, Shikhar Mohan, Brooke Trimmer, Tarq Bunch, Robert Ovadia and 3 more

Abstract read
In one paragraph

Article in Applied microscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Adedayo M SanniAnalytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Adedamola A OpaladeAnalytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Armen ShamirianAnalytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Spencer MattsonDevelopment and Technical Services, Gilead Sciences Inc, La Verne, CA, 91750, USA.
Eric DriscollDevelopment and Technical Services, Gilead Sciences Inc, La Verne, CA, 91750, USA.
Michael St MartinDevelopment and Technical Services, Gilead Sciences Inc, La Verne, CA, 91750, USA.
Shikhar MohanAnalytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Brooke TrimmerAnalytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Tarq BunchDevelopment and Technical Services, Gilead Sciences Inc, La Verne, CA, 91750, USA.
Robert OvadiaProcess Technologies and Development, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Jungjoo YoonAnalytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Sarina MaPharmaceutical Development and Technology, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Chris FotiAnalytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA. Chris.Foti@gilead.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glass vials are the most widely used primary containers for the packaging of parenteral products due to their optical clarity, general inertness, and hermetic properties, but under certain circumstances, they can pose safety concerns. Most of these issues are related to the potential formation of glass particulates through delamination or precipitation, resulting from the chemical interaction between the drug product and the inner surface of the glass vial. Hence, it is imperative for pharmaceutical companies to conduct product-vial compatibility studies to determine the appropriate packaging/container closure system. To support this development activity, scientists need to develop analytical methods to detect subvisible glass particulates in parenteral products, along with the appropriate positive controls, to facilitate detection and identification. This paper outlines the utilization of coaxial/episcopic and oblique illumination microscopy, combined with spectroscopic techniques, to detect thin glass particulates generated from a modified procedure. It also showcases the importance of angle-dependent lighting in visualizing positive control samples containing thin glass particulates. The analytical microscopy techniques discussed in this paper can assist scientists in selecting suitable container closure systems for developing parenteral products.

Indexed as

Coaxial illuminationGlass delaminationLamellaeMicrospectroscopyOblique illuminationOptical microscopyParenteral drugsThin-film interference

Identifiers

PMID39441435
PMCPMC11499564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.